5:28 PM ET
8-K
Leadership Change
Estrella Immunopharma Leadership Change
Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board, effective October 25, 2026. She succeeds Cheng Liu, Ph.D., who transitioned to the role of Chief Scientific Officer while remaining President and a director. Ms. Pussinen's employment agreement includes an initial base salary of $250,000 with automatic increases tied to future funding milestones.